These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1919652)

  • 21. In Vitro Antibiotic Susceptibility of Pseudomonas aeruginosa Corneal Ulcer Isolates.
    Gupta S; Mittal S; Nayak N; Satpathy G; Khokhar S; Agarwal T
    Ocul Immunol Inflamm; 2015 Jun; 23(3):252-5. PubMed ID: 24564536
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic potential of the antimicrobial peptide OH-CATH30 for antibiotic-resistant Pseudomonas aeruginosa keratitis.
    Li SA; Liu J; Xiang Y; Wang YJ; Lee WH; Zhang Y
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3144-50. PubMed ID: 24637683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
    Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
    CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gentamicin-resistant Pseudomonas aeruginosa corneal ulcers.
    Gelender H; Rettich C
    Cornea; 1984; 3(1):21-6. PubMed ID: 6443074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis.
    Silbiger J; Stern GA
    Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe Pseudomonas aeruginosa keratitis shortly after initiation of corneal refractive therapy.
    Priel A; Grinbaum A; Barequet IS
    Eye Contact Lens; 2006 Jan; 32(1):1-2. PubMed ID: 16415684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
    Levy JH; Katz HR
    Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extensively and pan-drug resistant Pseudomonas aeruginosa keratitis: clinical features, risk factors, and outcome.
    Fernandes M; Vira D; Medikonda R; Kumar N
    Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):315-22. PubMed ID: 26537122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic considerations in the treatment of bacterial keratitis.
    Callegan MC; O'Callaghan RJ; Hill JM
    Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Kowalski RP; Romanowski EG; Mah FS; Shanks RM; Gordon YJ
    Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.
    Chatterjee S; Agrawal D
    Indian J Ophthalmol; 2016 Feb; 64(2):153-7. PubMed ID: 27050354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of topical ceftazidime on pseudomonas keratitis in rabbits.
    Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H
    Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. True prophylactic gentamicin application in experimental Pseudomonas keratitis.
    Insler MS; Robbins RG; Martinez MT; Johnson MK
    CLAO J; 1988; 14(3):148-50. PubMed ID: 3208430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
    Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
    J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gentamicin penetration in the aqueous humor of eyes with corneal ulcers.
    Sloan SH; Pettit TH; Litwack KD
    Am J Ophthalmol; 1972 May; 73(5):750-3. PubMed ID: 4623935
    [No Abstract]   [Full Text] [Related]  

  • 37. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
    Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U
    Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pseudomonas keratitis after laser in situ keratomileusis.
    Sharma N; Sinha R; Singhvi A; Tandon R
    J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pseudomonas aeruginosa corneal abscess refractory to fluoroquinolones].
    Díaz Valle D; Alós Cortés JI; Arteaga Sánchez A; Toledano Fernández N; Poza Morales Y; Díaz-Valle T
    Arch Soc Esp Oftalmol; 2002 Jul; 77(7):397-9. PubMed ID: 12098814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical ciprofloxacin treatment of Pseudomonas keratitis in rabbits.
    O'Brien TP; Sawusch MR; Dick JD; Gottsch JD
    Arch Ophthalmol; 1988 Oct; 106(10):1444-6. PubMed ID: 3140772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.